Floatz logo

Vortioxetine

Freezing of Gait

Marianna AmboniSmall moleculePhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Freezing of Gait cohort.

Asset / SponsorPhaseRating
Strattera
Radboud University Medical Center
Phase 3BB
Amantadine
Seoul National University Hospital
Phase 4B
Droxidopa
Henry Ford Health System
Phase 2CCC

Same molecule, other indications

Vortioxetine is also rated in:

major depressive disorderDormant
BBB
Indicative ·
75 / 100
View asset →
bipolar depressionDormant
BB
Indicative ·
69 / 100
View asset →
anxiety disorderDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →